|Systematic (IUPAC) name|
|Mol. mass||327.417 g/mol|
|(what is this?)|
Benactyzine is an anticholinergic drug that was used as an antidepressant in the treatment of depression and associated anxiety before it was pulled from the U.S. market by the FDA due to its ineffectiveness.
Brand names have included: Suavitil, Phebex, Phobex, Cedad, Cevanol, Deprol, Lucidil, Morcain, Nutinal, Parasan. While there was some tentative evidence when combined with meprobamate with the medication no longer available it is not clinical important.
- Shorter, E., Looking backwards: a possible new path for drug discovery in psychopharmacology. Nat Rev Drug Discov 2002, 1 (12), 1003-1006.
- DeBattista, Alan F. Schatzberg, Jonathan O. Cole, Charles (2010). Manual of clinical psychopharmacology (7th ed. ed.). Washington, DC: American Psychiatric Pub. p. 423. ISBN 9781585623778.
- Smith, Mickey C., PhD. Principles of Pharmaceutical Marketing, Third Edition. 3rd ed. New York: Routledge, 2013. Print. ISBN 9781317940715
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|